Journal of Hematology & Thromboembolic Diseases : Citations & Metrics Report
Articles published in Journal of Hematology & Thromboembolic Diseases have been cited by esteemed scholars and scientists all around the world. Journal of Hematology & Thromboembolic Diseases has got h-index 16, which means every article in Journal of Hematology & Thromboembolic Diseases has got 16 average citations.
Following are the list of articles that have cited the articles published in Journal of Hematology & Thromboembolic Diseases.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles  | 
                                                  61 | 65 | 62 | 50 | 23 | 6 | 15 | 27 | 26 | 56 | 70 | 25 | 
Research, Review articles and Editorials  |                        
                                                6 | 19 | 17 | 27 | 8 | 5 | 7 | 21 | 18 | 37 | 59 | 21 | 
Research communications, Review communications, Editorial communications, Case reports and Commentary  |                        
                                                 28 | 46 | 39 | 23 | 14 | 1 | 5 | 6 | 8 | 14 | 24 | 4 | 
Conference proceedings  | 
                                                  0 | 6 | 35 | 35 | 0 | 0 | 41 | 25 | 33 | 0 | 0 | 0 | 
Citations received as per Google Scholar, other indexing platforms and portals  |                        
                                                 82 | 96 | 141 | 153 | 144 | 131 | 107 | 118 | 119 | 66 | 40 | 4 | 
| Journal total citations count | 1065 | 
| Journal impact factor | 2.67 | 
| Journal 5 years impact factor | 4.32 | 
| Journal cite score | 4.94 | 
| Journal h-index | 16 | 
| Journal h-index since 2019 | 12 | 
Important citations (901)
			 altura bm (2016) hdfx: a novel immunomodulator and potential superbug super-warrior for hospitalized patients and battlefield casualties. int j vaccines res 3: 1-3. |     
    |
			 altura bm (2016) hdfx: a novel immunomodulator for the amelioration of hypovolemic shock in the or, cancer patients and on the battlefield. j clin med ther 1: 1. |     
    |
			 altura bm, gebrewold a, carella a, altura bt (2016) hdfx; potential new treatment and prophylactic against nonalcoholic steatohepatitis (nash) and subsequent hepatocellular carcinomas: is hypomagnesemia a complication of the disease. j alcohol drug depend 4: e133. |     
    |
			 Chen, s., and m. pan. (2013) "nfat signaling and bone homeostasis." journal of hematology & thromboembolic diseases . |     
    |
			 Mir, ana luisa, and graciana souza lordelo.(2013) "role of methylenetetrahydrofolate reductase (mthfr), glutathione s-transferases (gsts m1 and t1) and haptoglobin (hp) gene polymorphisms in susceptibility to chronic myeloid leukemia (cml)." journal of hematology & thromboembolic diseases . |     
    |
			 Adel, gouri, et al.(2013) "polycythemia vera and acute coronary syndromes: pathogenesis, risk factors and treatment." journal of hematology & thromboembolic diseases . |     
    |
			 bekadja ma, bouchama s, charef l, yafour n, entasoltan b, et al. (2013) efficacy of l-asparaginase combination therapy in localized extranodal nk/t-cell lymphoma: a single institution experience. journal of hematology & thromboembolic diseases. |     
    |
			 redman ra, chesney j (2013) interesting collision between an indolent b-cell lymphoma and a microsatellite unstable adenocarcinoma of the colon. journal of hematology & thromboembolic diseases. |     
    |
			 Liu, hongtao, and justin kline. (2013) "novel immunotherapy to eliminate minimal residual disease in aml patients." journal of hematology & thromboembolic diseases . |     
    |
			 tradtrantip l, asavapanumas n, phuan pw, verkman as (2014) potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model. plos one 9: e106824. |     
    |
			 Majeed, haroon, et al. (2013) "blood transfusion after total knee arthroplasty; comparison of drainage versus non-drainage." journal of hematology & thromboembolic diseases . |     
    |
			 Maria, salinas.(2013) "knowledge is not enough the prominence of the laboratory in clinical decision making through creative imagination, communication and leadership." journal of hematology & thromboembolic diseases . |     
    |
			 Brahimi, mohamed, et al.(2013) "the role of flow cytometry in the diagnosis of myelodysplasic syndromes." journal of hematology & thromboembolic diseases . |     
    |
			 Ozdemırkıran, fusun, et al.(2013) "prominent reactive plasmacytic proliferation presenting with transient pancytopenia: an unusual case." journal of hematology & thromboembolic diseases . |     
    |
			 ramakrishna r, gupta s, sarathy k, batterham m, kirsh g (2013) combined short course low molecular weight heparin and calf compression therapy in prevention of deep vein thrombosis after total knee replacement: a randomized prospective study. journal of hematology & thromboembolic diseases. |     
    |
			 wei, andrew h., mellissa brown, and mark guthridge (2013) "the regulation of mitochondrial metabolism by the bcl-2 family of pro-survival proteins: new therapeutic opportunities for targeting cancer cells." journal of hematology & thromboembolic diseases . |     
    |
			 saboor, muhammad, moinuddin moinuddin, and samina ilyas. (2013) "comparison of platelet cd markers between normal individuals and untreated patients with type 2 diabetes mellitus." journal of hematology & thromboembolic diseases . |     
    |
			 Farhan, shatha, et al.(2013) "the inevitable: donor derived chronic myeloid leukemia following matched related stem cell transplant for acute lymphoblastic leukemia." journal of hematology & thromboembolic diseases . |     
    |
			 jufar, alemayehu hailu, and tewabech zewde (2014) "prevalence of anemia among pregnant women attending antenatal care at tikur anbessa specialized hospital, addis ababa ethiopia." journal of hematology & thromboembolic diseases . |     
    |
			 yasaka m (2017) intracranial bleeding. intreatment of non-vitamin k antagonist oral anticoagulants 25-39. |     
    |